Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Protein Analysis Reagents
  4. Lysates
  5. Overexpression Lysates
  6. NBP207377

Novus Biologicals™ PD-L1 Overexpression Lysate
SDP

Catalog No. NBP207377 Shop All R&D Systems Products
Change view
Click to view available options
Quantity:
0.1 mg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
NBP207377 0.1 mg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. NBP207377 Supplier Novus Biologicals™ Supplier No. NBP207377
Only null left
Add to Cart
Add to Cart

Description

The PD-L1 Overexpression Lysate is derived from human. It has been validated for the following applications: Western Blot.

Specifications

Cell Line The lysate was created in HEK293T cells, using plasmid ID RC215316 and based on accession number NP_54862. The protein contains a C-terminal DDK tag.
For Use With (Application) Western Blot
Quantity 0.1 mg
Storage Buffer RIPA buffer
Purity Protein
Test Specificity Homo sapiens CD274, mRNA.
Content And Storage Store at -80 C. Avoid freeze-thaw cycles.
Research Category Autoimmune Diseases, Cancer, Cellular Markers, Checkpoint signaling, Immune System Diseases, Immunology, Signal Transduction, Tumor Biomarkers, Tumor Suppressors
Target PD-L1
Synonym Avelumab, B7-H, B7-H1, B7H1PDCD1L1, CD274 antigenMGC142294, CD274 molecule, PDCD1LG1MGC142296, PD-L1, PD-L1B7 homolog 1, PDL1PDCD1 ligand 1, programmed cell death 1 ligand 1, Programmed death ligand 1
Gene Symbol CD274
Protein State Native
Show More Show Less

For Research Use Only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.